Cold Sore Treatment Market Size is Estimated to grow at a CAGR of 6.6% during the forecast period
The cold sore treatment market was
estimated to be worth USD 825.24 million in 2022, and over the forecast period,
a CAGR of 6.6% is anticipated. On the lips or surrounding the mouth, a cold
sore develops. One of the main factors contributing to the market's expansion
is the increased incidence of HSV infection worldwide.
HSV raises the risk of contracting and spreading HIV
infection as well as serious side effects like encephalitis. This is one of the
main drivers propelling the market's growth, along with the increasing number
of patients with chronic illnesses. The market is expanding as a result of
rising healthcare costs and investments in global healthcare infrastructure
improvement.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/cold-sore-treatment-market
Growth Drivers
The growing prevalence of the herpes simplex virus (HSV) is
increasing the need for efficient therapy. Sustained investigation and creation
of novel therapeutic alternatives, like topical creams and antiviral drugs,
improve patient convenience and effectiveness. The population's growing
understanding of the benefits of early treatment and preventive measures drives
up demand for over-the-counter medications.
The incidence of breakouts is increased by variables like
stress, reduced immunity, and exposure to triggers, which prompts people to
look for effective remedies. The industry is growing because customers are
prepared to spend money on wellness and healthcare items, which makes a range
of treatment alternatives available. Cold sore issues are more common in the
elderly population.
The market reach is expanded by the easier purchase
experience provided by the increased accessibility of cold sore treatments
through online platforms and e-commerce facilities. The market is expanding due
to rising demand for antiviral drugs used to treat cold sores. In addition to
painkillers, lip balms and lotions are being used more often for therapeutic
purposes.
Segmentation
Therapeutics Type
· Antiviral
Agents
· Analgesic
Agents
· Lysine
· Propolis
· Penciclovir
· Famciclovir
· Rhubarb
and Sage
· Acyclovir
· Others
Drug Type
· Branded
· Generics
End-Users
· Home-Care
· Specialty
Clinics
· Others
Distribution
Channel
· Hospital
Pharmacy
· Online
Pharmacy
· Retail
Pharmacy
· Others
Dosage Form
· Tablet
· Capsule
· Ointment
· Others
Regional Outlook
· Asia
Pacific
· North
America
· Latin
America
· Europe
· Middle
East and Africa
Key Players
· Pfizer
· Novartis
· GlaxoSmithKline
plc
· Teva
Pharmaceuticals Industries ltd.
· Sanofi
· AstraZeneca
· Bayer
AG
· Merck.
and Co.
· Aurobindo
Pharma
· Bausch
Health Companies
· Eli
Lilly and Company
· Bristol
Myers Squibb Company
· Cipla
Inc.
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/cold-sore-treatment-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment